AU2002225174A1 - Method of identifying modulators of nogo-functions - Google Patents

Method of identifying modulators of nogo-functions

Info

Publication number
AU2002225174A1
AU2002225174A1 AU2002225174A AU2002225174A AU2002225174A1 AU 2002225174 A1 AU2002225174 A1 AU 2002225174A1 AU 2002225174 A AU2002225174 A AU 2002225174A AU 2002225174 A AU2002225174 A AU 2002225174A AU 2002225174 A1 AU2002225174 A1 AU 2002225174A1
Authority
AU
Australia
Prior art keywords
nogo
functions
identifying modulators
modulators
identifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002225174A
Other languages
English (en)
Inventor
Walter Philip Blackstock
Richard Stephen Hale
Rabinder Prinjha
Adele Rowley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Glaxo Group Ltd
Original Assignee
SmithKline Beecham Ltd
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd, Glaxo Group Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2002225174A1 publication Critical patent/AU2002225174A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU2002225174A 2001-01-18 2002-01-18 Method of identifying modulators of nogo-functions Abandoned AU2002225174A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0101312.7A GB0101312D0 (en) 2001-01-18 2001-01-18 Assay
GB0101312.7 2001-01-18
PCT/GB2002/000228 WO2002057483A2 (en) 2001-01-18 2002-01-18 Method of identifying modulators of nogo-functions

Publications (1)

Publication Number Publication Date
AU2002225174A1 true AU2002225174A1 (en) 2002-07-30

Family

ID=9907052

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002225174A Abandoned AU2002225174A1 (en) 2001-01-18 2002-01-18 Method of identifying modulators of nogo-functions

Country Status (6)

Country Link
US (2) US7270962B2 (https=)
EP (1) EP1390758A2 (https=)
JP (1) JP2004520041A (https=)
AU (1) AU2002225174A1 (https=)
GB (1) GB0101312D0 (https=)
WO (1) WO2002057483A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011130347A2 (en) * 2010-04-13 2011-10-20 The Johns Hopkins University Methods for enhancing axonal regeneration
CN119768424A (zh) * 2022-08-22 2025-04-04 舒泰神（北京）生物制药股份有限公司 特异性识别Nogo-A的抗体及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ304224B6 (cs) * 1998-11-06 2014-01-15 Schwab Monoklonální protilátka
US7087399B1 (en) * 1999-05-13 2006-08-08 Scios, Inc. β-secretase and modulation of β-secretase activity
IL150566A0 (en) 2000-01-12 2003-02-12 Univ Yale Nucleic acids and polypeptides and nogo-receptor proteins
GB0101313D0 (en) 2001-01-18 2001-02-28 Glaxo Group Ltd Assay

Also Published As

Publication number Publication date
GB0101312D0 (en) 2001-02-28
US7270962B2 (en) 2007-09-18
JP2004520041A (ja) 2004-07-08
US20070286851A1 (en) 2007-12-13
US20040132096A1 (en) 2004-07-08
WO2002057483A2 (en) 2002-07-25
WO2002057483A3 (en) 2003-04-24
EP1390758A2 (en) 2004-02-25

Similar Documents

Publication Publication Date Title
AU2002303584A1 (en) Method for identifying comparable instruments
AU2002233633A1 (en) Method of transferring selected molecules
AU2002302243A1 (en) Method for determination of co-occurences of attributes
AU2002321549A1 (en) Method of providing information
AU2002364124A1 (en) Methods for identifying modulators of apoptosis
AU2002246346A1 (en) Method of identifying phosphoprotein
AU2002320460A1 (en) Calcineurin modulators
AU2002341150A1 (en) Method
AU2002225169A1 (en) Method for identifying modulators of bace
AU2002354363A1 (en) Method of activating protein
AU2002332927A1 (en) Method of preventing mucositis
AU2001237633A1 (en) Method of identifying modulators of presenilin
AU2002225174A1 (en) Method of identifying modulators of nogo-functions
AUPR633101A0 (en) Method
AU2002367917A1 (en) Method for identifying interaction partners using phage display
AU2002252802A1 (en) Method for identifying modulators of transcription
AU2002300513A1 (en) Method of Border Management
AU2002226538A1 (en) Method of alignment
AU2002319704A1 (en) Method of identifying nmda-related agent
AUPR433501A0 (en) New method of advertising
AU2002311913A1 (en) Method of use
AU2002364192A1 (en) Method of identifying novel proteins
AU2002228522A1 (en) Method of teaching (variants)
AUPR614401A0 (en) Method of obtaining information
AU2002344818A1 (en) Methods for identifying modulators of nf-kb activity

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase